- Report
- July 2026
- 195 Pages
Global
From €3174EUR$3,545USD£2,725GBP
€3526EUR$3,939USD£3,027GBP
- Report
- February 2026
- 250 Pages
Global
From €4020EUR$4,490USD£3,451GBP
- Report
- February 2026
- 250 Pages
Global
From €4020EUR$4,490USD£3,451GBP
- Report
- August 2026
- 152 Pages
Global
From €5237EUR$5,850USD£4,496GBP
- Report
- July 2026
- 160 Pages
Global
From €3715EUR$4,150USD£3,190GBP
- Report
- September 2025
- 150 Pages
Global
From €4342EUR$4,850USD£3,728GBP
- Report
- April 2026
- 120 Pages
Global
From €5327EUR$5,950USD£4,573GBP
- Report
- January 2026
- 185 Pages
Global
From €4029EUR$4,500USD£3,459GBP
- Report
- July 2026
- 250 Pages
Global
From €4020EUR$4,490USD£3,451GBP
- Report
- February 2026
- 250 Pages
Global
From €4020EUR$4,490USD£3,451GBP
- Report
- May 2026
- 147 Pages
Global
From €3536EUR$3,950USD£3,036GBP
- Report
- February 2026
- 195 Pages
Global
From €4342EUR$4,850USD£3,728GBP
- Report
- August 2026
- 602 Pages
Global
From €4024EUR$4,495USD£3,455GBP
- Report
- June 2026
- 336 Pages
Global
From €4296EUR$4,799USD£3,688GBP
- Report
- May 2026
- 468 Pages
Global
From €6401EUR$7,150USD£5,495GBP
- Report
- March 2026
- 150 Pages
Global
From €5327EUR$5,950USD£4,573GBP
- Report
- June 2026
- 187 Pages
Global
From €3174EUR$3,545USD£2,725GBP
€3526EUR$3,939USD£3,027GBP
- Report
- June 2026
- 182 Pages
Global
From €3174EUR$3,545USD£2,725GBP
€3526EUR$3,939USD£3,027GBP
- Report
- June 2026
- 200 Pages
Global
From €2677EUR$2,990USD£2,298GBP
- Report
- January 2026
- 326 Pages
Global
From €4029EUR$4,500USD£3,459GBP

A diagnostic biomarker is a biological molecule or gene that is used to identify a particular disease or condition. It is used to diagnose, monitor, and predict the progression of a disease or condition. Diagnostic biomarkers are used to detect the presence of a disease or condition, to determine the severity of the disease or condition, and to monitor the effectiveness of treatments. Diagnostic biomarkers are used in a variety of medical fields, including oncology, neurology, cardiology, and infectious diseases.
Diagnostic biomarkers are typically identified through a variety of methods, including genetic sequencing, proteomics, and metabolomics. These methods allow for the identification of biomarkers that are specific to a particular disease or condition.
The diagnostic biomarker market is a rapidly growing field, with many companies developing and marketing diagnostic biomarkers. Companies in this market include Illumina, Thermo Fisher Scientific, Qiagen, Roche, and Agilent Technologies. Show Less Read more